Home › Decisions › ABBV 2026-06-16

ABBV FDA decision — Jun 16, 2026

✓ APPROVED

AbbVie Inc. — JUVÉDERM - (SKINVIVE) (injectable HA) · neck lines.

Run-up into the decision (T-120 → T+5)

Daily close, T-120 (12/30/25) through T+5. Run-up high $236.19 on 3/6/26, low $197.38 on 4/28/26 (T-120 to T-1). FDA decision 6/16/26. Historical price action, not a forecast.

Key facts

FDA decision date2026-06-16

OutcomeApproved

Drug / candidateJUVÉDERM - (SKINVIVE) (injectable HA)

CompanyAbbVie Inc.

120-day run-up (T-120→T-1)-2.8%